Published in J Wildl Dis on July 01, 2009
Unexpected rarity of the pathogen Batrachochytrium dendrobatidis in Appalachian Plethodon Salamanders: 1957-2011. PLoS One (2014) 0.88
High occupancy of stream salamanders despite high ranavirus prevalence in a southern appalachians watershed. Ecohealth (2013) 0.78
Resistance to chytridiomycosis in European plethodontid salamanders of the genus Speleomantes. PLoS One (2013) 0.76
Ecology: The Convention on Biological Diversity's 2010 target. Science (2005) 5.22
Short-course antiretroviral therapy in primary HIV infection. N Engl J Med (2013) 4.82
Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia. N Engl J Med (2003) 4.19
Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr (2014) 2.79
Southern Ocean iron enrichment experiment: carbon cycling in high- and low-Si waters. Science (2004) 2.43
Geographic distribution of babesiosis among dogs in the United States and association with dog bites: 150 cases (2000-2003). J Am Vet Med Assoc (2005) 1.93
CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial. Lancet (2006) 1.91
Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks. Int J Epidemiol (2002) 1.79
Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial. AIDS (2003) 1.76
Prolonged transcriptional silencing and CpG methylation induced by siRNAs targeted to the HIV-1 promoter region. J RNAi Gene Silencing (2005) 1.57
Development and evaluation of a seminested PCR for detection and differentiation of Babesia gibsoni (Asian genotype) and B. canis DNA in canine blood samples. J Clin Microbiol (2003) 1.55
Processing interaural cues in sound segregation by young and middle-aged brains. J Am Acad Audiol (2009) 1.54
Development of HIV with drug resistance after CD4 cell count-guided structured treatment interruptions in patients treated with highly active antiretroviral therapy after dual-nucleoside analogue treatment. Clin Infect Dis (2005) 1.52
Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosine. AIDS (2005) 1.52
Safety of enfuvirtide in combination with an optimized background of antiretrovirals in treatment-experienced HIV-1-infected adults over 48 weeks. J Acquir Immune Defic Syndr (2005) 1.50
Synergistic attenuation of vesicular stomatitis virus by combination of specific G gene truncations and N gene translocations. J Virol (2006) 1.42
Multidisciplinary approach to the challenge of hemostasis. Anesth Analg (2009) 1.37
Autochthonous visceral leishmaniasis in dogs in North America. J Am Vet Med Assoc (2005) 1.34
Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtide: consensus recommendations. AIDS (2004) 1.28
A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration. Clin Cancer Res (2012) 1.28
Single-tube nested PCR for detection of tritrichomonas foetus in feline feces. J Clin Microbiol (2002) 1.16
The quality of drinking water from private water supplies in Aberdeenshire, UK. Water Res (2003) 1.15
Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection. AIDS (2002) 1.14
Detection of Rickettsia amblyommii in association with a tick bite rash. Vector Borne Zoonotic Dis (2007) 1.13
Detection of two Bartonella tamiae-like sequences in Amblyomma americanum (Acari: Ixodidae) using 16S-23S intergenic spacer region-specific primers. J Med Entomol (2008) 1.13
Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector. Springer Semin Immunopathol (2006) 1.12
Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy. PLoS One (2013) 1.11
Low levels of perforin expression in CD8+ T lymphocyte granules in lymphoid tissue during acute human immunodeficiency virus type 1 infection. J Infect Dis (2002) 1.10
Randomized, open-label, comparative trial to evaluate the efficacy and safety of three antiretroviral drug combinations including two nucleoside analogues and nevirapine for previously untreated HIV-1 Infection: the OzCombo 2 study. HIV Clin Trials (2002) 1.09
Capsular polysaccharides are an important immune evasion mechanism for Staphylococcus aureus. Hum Vaccin Immunother (2012) 1.08
Assessment of stream ecosystem function and sensitivity in the Bighorn National Forest, Wyoming. Environ Manage (2007) 1.07
Efficacy of combined atovaquone and azithromycin for therapy of chronic Babesia gibsoni (Asian genotype) infections in dogs. J Vet Intern Med (2004) 1.07
Cytauxzoon felis infection in cats in the mid-Atlantic states: 34 cases (1998-2004). J Am Vet Med Assoc (2006) 1.06
Harvesting the high-hanging fruit: the structure of the YdeN gene product from Bacillus subtilis at 1.8 angstroms resolution. Acta Crystallogr D Biol Crystallogr (2004) 1.04
Baylisascaris procyonis in raccoons (Procyon lotor) from North Carolina and current status of the parasite in the USA. Parasitol Res (2012) 1.03
Prevalence of and risk factors for feline Tritrichomonas foetus and giardia infection. J Clin Microbiol (2004) 1.03
Establishing a context for river rehabilitation, North Fork Gunnison River, Colorado. Environ Manage (2005) 1.03
Outcome of cats with diarrhea and Tritrichomonas foetus infection. J Am Vet Med Assoc (2004) 1.02
Role of conformational dynamics in α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor partial agonism. J Biol Chem (2012) 1.01
Efficacy of ronidazole for treatment of feline Tritrichomonas foetus infection. J Vet Intern Med (2006) 0.99
Dynamics of T cells and TCR excision circles differ after treatment of acute and chronic HIV infection. J Immunol (2002) 0.99
Structure and function of Bacillus subtilis YphP, a prokaryotic disulfide isomerase with a CXC catalytic motif . Biochemistry (2009) 0.97
Comparison of serological and molecular panels for diagnosis of vector-borne diseases in dogs. Parasit Vectors (2014) 0.97
Development of a multicomponent Staphylococcus aureus vaccine designed to counter multiple bacterial virulence factors. Hum Vaccin Immunother (2012) 0.96
In vivo biodistribution of a highly attenuated recombinant vesicular stomatitis virus expressing HIV-1 Gag following intramuscular, intranasal, or intravenous inoculation. Vaccine (2009) 0.95
A myristoylated alanine-rich C kinase substrate-related peptide suppresses cytokine mRNA and protein expression in LPS-activated canine neutrophils. Am J Respir Cell Mol Biol (2012) 0.95
Use of a commercially available culture system for diagnosis of Tritrichomonas foetus infection in cats. J Am Vet Med Assoc (2003) 0.94
Nucleoside analogue mutations and Q151M in HIV-1 subtype A/E infection treated with nucleoside reverse transcriptase inhibitors. AIDS (2003) 0.93
Pharmacokinetics and pharmacodynamics of indinavir with or without low-dose ritonavir in HIV-infected Thai patients. J Antimicrob Chemother (2003) 0.93
Molecular characterization of trichomonads from feces of dogs with diarrhea. J Parasitol (2005) 0.92
Serosurvey of antiBabesia antibodies in stray dogs and American pit bull terriers and American staffordshire terriers from North Carolina. J Am Anim Hosp Assoc (2004) 0.91
An unusual case of peritonitis in an intravenous drug user. Gastroenterology (2011) 0.91
Identification of Pentatrichomonas hominis in feline fecal samples by polymerase chain reaction assay. Vet Parasitol (2006) 0.91
Concurrent bartonellosis and babesiosis in a dog with persistent thrombocytopenia. J Am Vet Med Assoc (2003) 0.91
Does physical activity in adolescence have site-specific and sex-specific benefits on young adult bone size, content, and estimated strength? J Bone Miner Res (2014) 0.89
Creation of a drug fund for post-clinical trial access to antiretrovirals. Lancet (2004) 0.89
Modification of the QuantiFERON-TB Gold (In-Tube) assay for the diagnosis of Mycobacterium bovis infection in African buffaloes (Syncerus caffer). Vet Immunol Immunopathol (2011) 0.88
Influence of vascular porosity on fluid flow and nutrient transport in loaded cortical bone. J Biomech (2008) 0.88
Strengthening international cooperation for health and biodiversity. Ecohealth (2012) 0.87
A national framework for disaster health education in Australia. Prehosp Disaster Med (2010) 0.87
Efficacy of tinidazole for treatment of cats experimentally infected with Tritrichomonas foetus. Am J Vet Res (2007) 0.85
Optimization of a species-specific polymerase chain reaction assay for identification of Pentatrichomonas hominis in canine fecal specimens. Am J Vet Res (2007) 0.85
A randomized phase 3 study comparing once-daily elvitegravir with twice-daily raltegravir in treatment-experienced subjects with HIV-1 infection: 96-week results. J Acquir Immune Defic Syndr (2013) 0.85
Infection and replication of Bartonella species within a tick cell line. Exp Appl Acarol (2009) 0.84
Herpes simplex virus type 2 UL24 gene is a virulence determinant in murine and guinea pig disease models. J Virol (2005) 0.84
Joint statement on mechanical circulatory support in children: a consensus review from the Pediatric Cardiac Intensive Care Society and Extracorporeal Life Support Organization. Pediatr Crit Care Med (2013) 0.84
Improved compressed sensing-based algorithm for sparse-view CT image reconstruction. Comput Math Methods Med (2013) 0.84
Expression and function of triggering receptor expressed on myeloid cells-1 (TREM-1) on canine neutrophils. Dev Comp Immunol (2011) 0.84
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults. Hum Vaccin Immunother (2015) 0.83
Efficacy and safety of three doses of tipranavir boosted with ritonavir in treatment-experienced HIV type-1 infected patients. AIDS Res Hum Retroviruses (2007) 0.83
X-ray diffraction enhanced imaging as a novel method to visualize low-density scaffolds in soft tissue engineering. Tissue Eng Part C Methods (2011) 0.82
Limited evolution of HIV antiretroviral drug resistance-associated mutations during the performance of drug resistance testing. J Acquir Immune Defic Syndr (2003) 0.82
Pharmacokinetics of reduced-dose indinavir/ritonavir 400/100 mg twice daily in HIV-1-infected Thai patients. Antivir Ther (2005) 0.82
Variability in time delay between two models of pulse oximeters for deriving the photoplethysmographic signals. Physiol Meas (2005) 0.82
Highly active antiretroviral therapy (HAART) retreatment in patients on CD4-guided therapy achieved similar virologic suppression compared with patients on continuous HAART: the HIV Netherlands Australia Thailand Research Collaboration 001.4 study. J Acquir Immune Defic Syndr (2005) 0.82
Motor coordination difficulties and physical fitness of extremely-low-birthweight children. Dev Med Child Neurol (2008) 0.81
Extending single molecule fluorescence observation time by amplitude-modulated excitation. Methods Appl Fluoresc (2013) 0.81
Transmission of Batrachochytrium dendrobatidis to wood frogs (Lithobates sylvaticus) via a bullfrog (L. catesbeianus) vector. J Wildl Dis (2012) 0.81
The importance, and important limitations, of ultrasound imaging for evaluating thyroid nodules. JAMA Intern Med (2013) 0.81
False negative HIV-1 proviral DNA polymerase chain reaction in a patient with primary infection acquired in Thailand. J Clin Virol (2003) 0.80
Plasticizer metabolites in the environment. Water Res (2004) 0.80
Development and evaluation of a PCR assay for the detection of Cytauxzoon felis DNA in feline blood samples. Vet Parasitol (2006) 0.80
Thyroglobulin measurements in fine-needle aspiration cytology of lymph nodes for the detection of metastatic papillary thyroid carcinoma. Cancer Cytopathol (2013) 0.80
Experimental infection by capillary tube feeding of Rhipicephalus sanguineus with Bartonella vinsonii subspecies berkhoffii. Comp Immunol Microbiol Infect Dis (2011) 0.79
Reduced soil water availability did not protect two competing grassland species from the negative effects of increasing background ozone. Environ Pollut (2012) 0.78
A novel candidate vaccine for cytauxzoonosis inferred from comparative apicomplexan genomics. PLoS One (2013) 0.78
Gene expression analysis and urinary biomarker assays reveal activation of tubulointerstitial injury pathways in a rodent model of chronic proteinuria (Doxorubicin nephropathy). Nephron Exp Nephrol (2013) 0.78
Web-based therapeutic exercise resource center as a treatment for knee osteoarthritis: a prospective cohort pilot study. BMC Musculoskelet Disord (2014) 0.78
Heterobilharzia americana infection in a dog. J Am Vet Med Assoc (2002) 0.78
Successful management of lymphangiomatosis and chylothorax in a 7-month-old infant. J Paediatr Child Health (2006) 0.78
Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV Infection. J Acquir Immune Defic Syndr (2016) 0.77
Molecular characterization of a Babesia species identified in a North American raccoon. J Wildl Dis (2006) 0.77
Pharmacogenomics of Cytauxzoon felis cytochrome b: implications for atovaquone and azithromycin therapy in domestic cats with cytauxzoonosis. J Clin Microbiol (2013) 0.77